Sales have risen steadily since, with Waterlase winning subsequent approvals for root canals in January 2002, bone surgery in February 2002 and root canal complications in February 2003.
Yet there is another, more obvious bone of contention, which exacerbates all these others and lies at the root of them: the 4, 000km border that runs between the two countries.